v3.26.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Gains on Interest Rate Swaps
The following table shows the (loss) gain and interest income on our interest rate swap contracts:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(Loss) gain recorded in accumulated other comprehensive loss, net of tax$— $(2)$1 $(10)
Interest income related to interest rate swap contracts recorded in interest expense1 3 4 8 
Schedule of Effect of Interest Rate Swap Contracts Designated as Cash Flow Hedges
The following table shows the effect of interest rate swap contracts designated as cash flow hedges on interest expense in the consolidated statements of income:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Total interest expense which reflects the effects of cash flow hedges$(80)$(84)$(243)$(229)
Hedged item(5)(5)(15)(15)
Derivative designated as hedging instrument6 8 19 23 
Schedule of Assets Measured at Fair Value on a Recurring Basis
The following table shows the fair value of our hedges:
As of
Hedge Type
Balance Sheet Line Item
September 30, 2026December 31, 2025
Interest rate swapsPrepaid expenses, deposits and other current assets$6 $— 
Interest rate swapsOther assets— 5 
Schedule of Changes in Contingent Acquisition Consideration Liabilities
The table below reconciles the change in the contingent acquisition consideration liabilities (including deferred purchase price) for the period from December 31, 2025 to September 30, 2026.
TotalIncluded in Accrued LiabilitiesIncluded in Other Long-Term Liabilities
Balance as of December 31, 2025
$88 $7 $81 
Fair value adjustments(1)
(11)
Other adjustments(2)
(7)
Balance as of September 30, 2026
$70 $13 $57 
(1) Amount included in Restructuring and other (see Note 4).
(2) Represents extinguishment of $7 million in redeemable non-controlling interest liability associated with SciPlay’s acquisition of Alictus Yazilim Anonim Şirketi in 2022, as the remaining interests were transferred to the Company during the second quarter of 2026 with no further consideration. The gain was recorded in other income (expense), net in our consolidated statements of operations.